Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - BioCardia, Inc. | ex_214686.htm |
| EX-31.2 - EXHIBIT 31.2 - BioCardia, Inc. | ex_214685.htm |
| EX-31.1 - EXHIBIT 31.1 - BioCardia, Inc. | ex_214684.htm |
| EX-23.2 - EXHIBIT 23.2 - BioCardia, Inc. | ex_235034.htm |
| EX-23.1 - EXHIBIT 23.1 - BioCardia, Inc. | ex_214683.htm |
| EX-21.1 - EXHIBIT 21.1 - BioCardia, Inc. | ex_214682.htm |
| EX-10.11 - EXHIBIT 10.11 - BioCardia, Inc. | ex_236740.htm |
| EX-4.4 - EXHIBIT 4.4 - BioCardia, Inc. | ex_237522.htm |
| 10-K - FORM 10-K - BioCardia, Inc. | bcda20201231_10k.htm |
Exhibit 32.2
Certification of Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, David McClung, the Vice President of Finance of BioCardia, Inc. (the "Company"), hereby certify, that, to my knowledge:
1. The Annual Report on Form 10-K for the year ended December 31, 2020 (the "Report") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 29, 2021
|
|
/s/ David McClung |
|
|
|
Name: David McClung |
|
|
|
Title: Chief Financial Officer |
|